TYSONS CORNER, VA, March 10, 2017 — A subsidiary of CSRA (NYSE: CSRA) has secured orphan drug status from the Food and
A Computer Sciences Corp. (NYSE: CSC) company has won a 10-year, $90 million follow-on contract to examine infectious disease therapeutics
